Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: A systematic review of clinical practice guidelines

Chest

Volumn 144, Issue 6, 2013, Pages 1848-1856

  Darvish Kazem, Saeed ^a   Gandhi, Mandark ^b   Marcucci, Maura ^a   Douketis, James D ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; THIENOPYRIDINE DERIVATIVE;

ANTIPLATELET THERAPY; BARE METAL STENT; CORONARY STENT; DRUG ELUTING STENT; DRUG WITHDRAWAL; ELECTIVE SURGERY; EVIDENCE BASED MEDICINE; HUMAN; NONCARDIAC SURGERY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; THERAPY;

ASPIRIN; CORONARY ARTERY DISEASE; HEMORRHAGE; HUMANS; METALS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; STENTS; SURGICAL PROCEDURES, ELECTIVE; THROMBOEMBOLISM; TICLOPIDINE; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 84890284476     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-0459     Document Type: Article

References (30)

1. Devereaux PJ, Chan M, Eikelboom J. Major vascular complications in patients undergoing non-cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence Based Cardiology. 3rd ed. West Sussex, England: Wiley-Blackwell; 2010:47-62.
2. Steinhubl SR, Berger PB, Mann JT III, et al CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288(19):2411-2420.
3. Bell AD, Roussin A, Cartier R, et al; Canadian Cardiovascular Society. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol. 2011;27(suppl A):S1-S59.
4. Chen TH, Matyal R. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery. Semin Cardiothorac Vasc Anesth. 2010;14(4):256-273.
5. Cruden NL, Harding SA, Flapan AD, et al; Scottish Coronary Revascularisation Register Steering Committee. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv. 2010;3(3):236-242.
6. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126-2130.
7. Wilson SH, Rihal CS, Bell MR, Velianou JL, Holmes DR Jr, Berger PB. Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin. Am J Cardiol. 1999;83(7):1006-1011.
8. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173(6):627-634.
9. Andersen K, Jóhannesdóttir BK, Kristjánsson JM, Gudnason T. Decreasing case fatality in myocardial infarction is explained by improved medical treatment. Acta Cardiol. 2011;66(1):39-45.
10. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155-2165.
11. Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg. 2001;88(6):787-800.
12. Fox KA, Mehta SR, Peters RJ, et al; Clopidogrel in unstable angina to prevent recurrent ischemic events trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome - the Clopidogrel in Unstable angina to prevent Recurrent Ischemic Events (CURE) Trial. Circulation. 2004;110(10):1202-1208.
13. Nuttall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology. 2008;109(4):588-595.
14. Abualsaud AO, Eisenberg MJ. Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv. 2010;3(2):131-142.
15. Albaladejo P, Marret E, Samama CM, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart. 2011;97(19):1566-1572.
16. PEP trial group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355(9212):1295-1302.
17. Brieger D, Allan R, Conroy M, et al; Cardiac Society of Australia and New Zealand. Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery. Heart Lung Circ. 2010;19(1):2-10.
18. Korte W, Cattaneo M, Chassot P-G, et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost. 2011;105(5):743-749.
19. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2-suppl):e326S-e350S.
20. Grines CL, Bonow RO, Casey DE Jr, et al; American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007;49(6):734-739.
21. Albaladejo P, Marret E, Piriou V, Samama CM; et Le Groupe de Travail. Management of oral antiplatelet treatment for patients with coronary stents [in French]. Ann Fr Anesth Reanim. 2006;25(7):796-798.
22. Poldermans D, Bax JJ, Boersma E, et al; Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery; European Society of Cardiology (ESC). Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Noncardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J. 2009;30(22):2769-2812.
23. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2009;120(21):e169- e276.
24. JCS Joint Working Group. Guidelines for perioperative cardiovascular evaluation and management for noncardiac surgery (JCS 2008) - digest version. Circ J. 2011;75(4):989-1009.
25. Danielson D, Bjork K, Foreman J, et al. Preoperative evaluation. Institute for Clinical Systems Improvement. 2012;10:1-61.
26. Gualandro DM, Yu PC, Calderaro D, et al. Steps to reduce surgical risk. In: II guidelines for perioperative evaluation. Arq Bras Cardiol. 2011;96(3)(Suppl 1):23-41.
27. Berger PB, Kleiman NS, Pencina MJ, et al EVENT Investigators. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010;3(9):920-927.
28. Mantz J, Samama CM, Tubach F, et al; Stratagem Study Group. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth. 2011;107(6):899-910.
29. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med. 2005;257(5):399-414.
30. Wilson SHFP, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003;42(2):234-240.